ENA Respiratory is a biotechnology company aiming to transform the treatment and prevention of respiratory infections in at-risk populations.
Ena Respiratory is developing novel, synthetic innate immunomodulators for the prevention of respiratory viral and bacterial infections. The company is based in Melbourne, Australia and it has secured a Series A investment from the Brandon Capital managed Medical Research Commercialisat...
ENA Respiratory is a biotechnology company aiming to transform the treatment and prevention of respiratory infections in at-risk populations.
Ena Respiratory is developing novel, synthetic innate immunomodulators for the prevention of respiratory viral and bacterial infections. The company is based in Melbourne, Australia and it has secured a Series A investment from the Brandon Capital managed Medical Research Commercialisation Fund (MRCF) and Uniseed.
Sponsored Ad
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.